SG11202011189TA - Novel modulator of metabotropic and ionotropic transmembrane receptors and use thereof - Google Patents
Novel modulator of metabotropic and ionotropic transmembrane receptors and use thereofInfo
- Publication number
- SG11202011189TA SG11202011189TA SG11202011189TA SG11202011189TA SG11202011189TA SG 11202011189T A SG11202011189T A SG 11202011189TA SG 11202011189T A SG11202011189T A SG 11202011189TA SG 11202011189T A SG11202011189T A SG 11202011189TA SG 11202011189T A SG11202011189T A SG 11202011189TA
- Authority
- SG
- Singapore
- Prior art keywords
- metabotropic
- transmembrane receptors
- novel modulator
- ionotropic
- ionotropic transmembrane
- Prior art date
Links
- 230000001057 ionotropic effect Effects 0.000 title 1
- 102000027257 transmembrane receptors Human genes 0.000 title 1
- 108091008578 transmembrane receptors Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2018117463A RU2697414C1 (en) | 2018-05-11 | 2018-05-11 | Novel tachykinin receptor antagonist and use thereof |
| PCT/RU2019/050060 WO2019216795A1 (en) | 2018-05-11 | 2019-05-07 | Novel modulator of metabotropic and ionotropic transmembrane receptors and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202011189TA true SG11202011189TA (en) | 2020-12-30 |
Family
ID=67640490
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202011189TA SG11202011189TA (en) | 2018-05-11 | 2019-05-07 | Novel modulator of metabotropic and ionotropic transmembrane receptors and use thereof |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US11414377B2 (en) |
| EP (1) | EP3792247A4 (en) |
| JP (1) | JP7301954B2 (en) |
| KR (1) | KR20210008061A (en) |
| CN (1) | CN112384495B (en) |
| AU (1) | AU2019267188B2 (en) |
| CA (1) | CA3099849A1 (en) |
| CL (1) | CL2020002908A1 (en) |
| CU (1) | CU24662B1 (en) |
| EA (1) | EA202092712A1 (en) |
| GE (1) | GEP20237454B (en) |
| IL (1) | IL278603B2 (en) |
| MA (1) | MA52582A (en) |
| MX (1) | MX2020012035A (en) |
| PH (1) | PH12020551928A1 (en) |
| RU (1) | RU2697414C1 (en) |
| SG (1) | SG11202011189TA (en) |
| WO (1) | WO2019216795A1 (en) |
| ZA (1) | ZA202007027B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2697414C1 (en) * | 2018-05-11 | 2019-08-14 | Общество с ограниченной ответственностью "АЙ БИ ДИ Терапевтикс" | Novel tachykinin receptor antagonist and use thereof |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4579841A (en) * | 1981-07-20 | 1986-04-01 | University Patents, Inc. | Dipeptide derivatives having opiate activity |
| US5610145A (en) * | 1994-04-15 | 1997-03-11 | Warner-Lambert Company | Tachykinin antagonists |
| KR100389253B1 (en) * | 1995-02-22 | 2003-08-19 | 노파르티스 아게 | 1-Aryl-2-Acylamino-Ethane Compounds And Their Use As Neurokinin Especially Neurokinin 1 Antagonists |
| MY132550A (en) * | 1996-08-22 | 2007-10-31 | Novartis Ag | Acylaminoalkenylene-amide derivatives as nk1 and nk2 antogonists |
| GB9907571D0 (en) | 1999-04-06 | 1999-05-26 | Zeneca Ltd | Compounds |
| ATE400563T1 (en) | 2000-04-06 | 2008-07-15 | Astrazeneca Ab | NEW NEUROKININ ANTAGONISTS FOR USE AS MEDICINAL PRODUCTS |
| WO2001077069A1 (en) | 2000-04-06 | 2001-10-18 | Astrazeneca Ab | Naphthamide neurokinin antagonists for use as medicaments |
| SE0003476D0 (en) | 2000-09-28 | 2000-09-28 | Astrazeneca Ab | Compounds |
| EP1295599A1 (en) | 2001-09-21 | 2003-03-26 | Boehringer Ingelheim International GmbH | Method for the treatment of prevention of atopic dermatitis |
| RU2309144C2 (en) * | 2005-03-25 | 2007-10-27 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Phenyl-containing n-acylamine derivatives, method for production thereof, pharmaceutical composition and uses thereof as anti-inflammatory and analgesic agents |
| CN107739316B (en) * | 2017-11-14 | 2020-07-14 | 中国医科大学 | Bromotyrosine alkaloid compound and preparation method and application thereof |
| RU2697414C1 (en) * | 2018-05-11 | 2019-08-14 | Общество с ограниченной ответственностью "АЙ БИ ДИ Терапевтикс" | Novel tachykinin receptor antagonist and use thereof |
-
2018
- 2018-05-11 RU RU2018117463A patent/RU2697414C1/en active
-
2019
- 2019-05-07 CN CN201980044155.6A patent/CN112384495B/en active Active
- 2019-05-07 KR KR1020207035511A patent/KR20210008061A/en unknown
- 2019-05-07 GE GEAP201915511A patent/GEP20237454B/en unknown
- 2019-05-07 US US17/054,686 patent/US11414377B2/en active Active
- 2019-05-07 SG SG11202011189TA patent/SG11202011189TA/en unknown
- 2019-05-07 WO PCT/RU2019/050060 patent/WO2019216795A1/en active Application Filing
- 2019-05-07 JP JP2021513748A patent/JP7301954B2/en active Active
- 2019-05-07 AU AU2019267188A patent/AU2019267188B2/en active Active
- 2019-05-07 MX MX2020012035A patent/MX2020012035A/en unknown
- 2019-05-07 CU CU2020000083A patent/CU24662B1/en unknown
- 2019-05-07 CA CA3099849A patent/CA3099849A1/en active Pending
- 2019-05-07 EP EP19799411.4A patent/EP3792247A4/en active Pending
- 2019-05-07 EA EA202092712A patent/EA202092712A1/en unknown
- 2019-05-07 IL IL278603A patent/IL278603B2/en unknown
- 2019-05-07 MA MA052582A patent/MA52582A/en unknown
-
2020
- 2020-11-09 CL CL2020002908A patent/CL2020002908A1/en unknown
- 2020-11-11 ZA ZA2020/07027A patent/ZA202007027B/en unknown
- 2020-11-11 PH PH12020551928A patent/PH12020551928A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA3099849A1 (en) | 2019-11-14 |
| EA202092712A1 (en) | 2021-02-17 |
| EP3792247A1 (en) | 2021-03-17 |
| IL278603A (en) | 2021-03-01 |
| PH12020551928A1 (en) | 2021-06-14 |
| EP3792247A4 (en) | 2022-01-12 |
| CU24662B1 (en) | 2023-05-11 |
| MX2020012035A (en) | 2021-03-29 |
| AU2019267188B2 (en) | 2024-02-15 |
| IL278603B1 (en) | 2023-11-01 |
| JP7301954B2 (en) | 2023-07-03 |
| RU2697414C1 (en) | 2019-08-14 |
| US20210070692A1 (en) | 2021-03-11 |
| KR20210008061A (en) | 2021-01-20 |
| CU20200083A7 (en) | 2021-06-08 |
| ZA202007027B (en) | 2022-08-31 |
| AU2019267188A1 (en) | 2020-11-26 |
| MA52582A (en) | 2021-03-17 |
| IL278603B2 (en) | 2024-03-01 |
| CN112384495B (en) | 2023-07-18 |
| WO2019216795A1 (en) | 2019-11-14 |
| CN112384495A (en) | 2021-02-19 |
| CL2020002908A1 (en) | 2021-03-26 |
| BR112020022807A2 (en) | 2021-02-02 |
| US11414377B2 (en) | 2022-08-16 |
| GEP20237454B (en) | 2023-01-10 |
| JP2021523235A (en) | 2021-09-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL282257A (en) | Androgen receptor modulators and methods for their use | |
| EP3436030A4 (en) | Chimeric receptors and methods of use thereof | |
| IL276402A (en) | Use of lentiviral vector expressing fviii | |
| EP3962527A4 (en) | Chimeric receptors and methods of use thereof | |
| MA40921A (en) | ANTI-GENETIC CHEMERICAL ANTI-CLDN RECEPTORS AND METHODS OF USE | |
| IL277495A (en) | Modulators of g-protein coupled receptors | |
| EP3638300A4 (en) | Fibronectin binding domain chimeric antigen receptors and methods of use thereof | |
| EP3600290A4 (en) | Novel modulators of the sigma-2 receptor and their method of use | |
| ZA202007027B (en) | Novel modulator of metabotropic and ionotropic transmembrane receptors and use thereof | |
| IL282003A (en) | Methods of making platelets comprising modified receptors and uses thereof | |
| PL3707143T3 (en) | New analogs as androgen receptor and glucocorticoid receptor modulators | |
| RS61334B1 (en) | Combinations comprising positive allosteric modulators of metabotropic glutamatergic receptor subtype 2 and their use | |
| ZA202000399B (en) | Heterocyclylmethylidene derivatives and their use as modulators of mglur5 receptors | |
| IL266624A (en) | Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use | |
| EP3463361A4 (en) | Dual modulators of both mu and kappa opioid receptors | |
| AU2015905333A0 (en) | Modulators of Endosomal G Protein-Coupled Receptors | |
| PT3431106T (en) | Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use | |
| AU2016902253A0 (en) | Modulators of protease activated receptors |